Early Career Research Grant for Rare Pulmonary Conditions

Longfonds-Swierenga grant 2025

Longfonds and the Swierenga Foundation are committed to advancing progress in the field of rare lung diseases. This 50,000 euro grant funds one-year exploratory projects, enabling early-career researchers to develop innovative ideas with potential for future breakthroughs.

Arts longfoto

Rare lung diseases are conditions affecting fewer than 1 in 2,000 people in the Netherlands. Due to their low prevalence, these diseases are often poorly understood, underdiagnosed, and underfunded, making research especially important and challenging. The Longfonds-Swierenga Grant supports early-stage, exploratory research in this field. More information about the Prof. dr. Jaap Swierenga Stichting. It is designed to help researchers test innovative ideas and hypotheses through small-scale studies that may lead to larger projects.

Grant details

  • Exclusively dedicated to rare pulmonary diseases, with the exception of lung cancer
  • The grant supports small-scale, exploratory studies aimed at testing novel ideas and paving the way for larger research projects
  • Applicants should outline long-term research plans if the pilot yield useful results
  • Maximum funding: 50,000 euro (smaller amounts possible)
  • Project duration: up to 1 year
  • Includes a midterm (online) progress meeting and a final report
  • Longfonds serves as the main contact and supervisor

Who can apply?

  • Early career researchers in PhD or postdoctoral positions, as well as medical doctors or residents and nurses considering a PhD track
  • Applicants must be affiliated with a Dutch institution, defined as a university (including affiliated academic medical centers, NKI, or KNAW institutes), hospitals linked to the Dutch Association of Top Clinical Teaching Hospitals (STZ), or general hospitals
  • Each applicant may submit only one proposal
  • A specific supervisor may fulfill this role for a maximum of two project proposals
  • Each research team/department may submit a maximum of two project proposals
  • Applicants are encouraged to involve patients or patient representatives

Application procedure

Submit a compact application using our Application Form, this includes: Applicant and project information; Research objectives and rationale; Methodology; Budget (max. 50,000 euro) and justification; Timeline (max. 12 months); Ethical considerations; Expected impact and future plans; Patient involvement.

Proposals will be assessed on:

  • Innovation
  • Research question and hypothesis rationale
  • Study plan of the pilot project, including potential for larger follow-up research
  • Potential relevance to clinical practice or translational research
  • Distinctiveness and added value
  • Objectives and scientific justification

Review Process

An independent review committee, consisting of 4 members including a patient representative, will prioritize the submitted project proposals. The highest-ranked proposal is presented to the boards of Longfonds and Swierenga Foundation for approval and provision of the grant.
Note: There is no pre-proposal phase, and applicants are not required to pitch in person.

Timeline call 2025

  • Call for proposals: Thursday, 19 June
  • Proposal submission deadline: Thursday, 25 September before 2pm
  • Announcement of awarded projects: Thursday, 6 November
  • Project start date: Within 6 months of award notification

The Longfonds-Swierenga Grant will be awarded annually through 2029.

Contact

For any questions regarding the Longfonds-Swierenga Grant, please contact the Longfonds Research Team at research@longfonds.nl.